Washington, DC – The Board of Pharmacy Specialties (BPS) recently approved a practice analysis or role delineation study in Sterile Compounding. Conducting a role delineation study is a critical step in evaluating a proposed specialty. 

The purpose of the role delineation study is to determine whether this practice area is based upon specialized knowledge of the pharmaceutical sciences, as well as specialized functions routinely performed by practitioners in these proposed specialty.

BPS is pleased to announce that the members of the Practice Analysis Taskforce in Sterile Compounding are:


Gene B. Decaminada

Manager, Compounding Compliance

Option Care

Shelton, CT


Lisa Ginsberg-Evans

Pharmacist Manager, Clean Room and Sterile Products

University of Michigan Hospitals and Health System

Ann Arbor, MI


Michael A. Koch

Senior Vice President, Professional Services

Central Admixture Pharmacy Services

B.Braun CAPS

Irvine, CA


William Mixon


The Compounding Pharmacy

Hickory, NC


Anna Nowobilski-Vasilios


ANOVATION, Care Management Innovation

Chicago, IL


Pamella Ochoa

Assistant Professor

Texas Tech University Health Sciences Center School of Pharmacy

Abilene, TX


Kenneth Chase Parks

Master Instructor

Kennedy Pharmacy Innovation Center

South Carolina College of Pharmacy

Columbia, SC


Marc Stranz

marcstranz, inc.

Philadelphia, PA


Mark Sullivan

Director – Inpatient Pharmacy Operations

Vanderbilt University Hospital

Nashville, TN


Duann Thistlethwaite


National Association of Boards of Pharmacy

Jefferson, PA


Becky M. Triplett

Pharmacy Manager

University of Iowa Hospitals and Clinics

Iowa City, IA


Bruce Vinson

Manager Sterile Products, Cancer Infusion Centers, and Investigational Drugs

Cedars- Sinai Medical Center

Los Angeles, CA


Kara Weatherman

Clinical Associate Professor – Department of Pharmacy Practice

Director – Nuclear Pharmacy Programs

Purdue University College of Pharmacy

West Lafayette, IN


Aaron Webb

Pharmacy Manager

University of Wisconsin Hospital and Clinics

Madison, WI


Angela Yaniv

Assistant Director, Sterile Products

Cleveland Clinic

Cleveland, OH


The initial work of the practice analysis taskforce will be reviewed by an outside panel of subject matter experts and then validated via a survey administered to pharmacists practicing in the area. If the role delineation study in this area yields information suggestive that Sterile Compounding should be recognized as a specialty practice in pharmacy, BPS will then issue a call to the profession for a petition for new specialty recognition.


About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA).  The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world. Through the rigorous standards mandated by BPS board certification and recertification, the BPS board certified pharmacist stands out as the most qualified to accept today’s expanding professional expectations.  Today, more than 20,000 pharmacists are BPS board certified.

Press Release PDF